Apnat Tablets — Apalutamide 60 mg (120 Tablets) Natco
Apnat 60 mg (Apalutamide) is an advanced targeted therapy for the treatment of prostate cancer. It is a potent, selective androgen receptor inhibitor. By blocking the effect of testosterone on cancer cells, Apnat prevents them from dividing and growing, significantly slowing disease progression and the spread of metastases.
Manufacturer: NATCO Pharma. Apnat is a high-quality generic version of the brand-name drug Erleada, manufactured in compliance with international standards. It has been proven bioequivalent to the reference product, offering the same therapeutic efficacy at a more affordable cost.
Key Features:
- ✅ Hormonal Blockade: Effectively inhibits the androgen signaling pathway that fuels prostate cancer growth.
- ✅ Oral Administration: Convenient tablet form for daily use.
- 💊 Established Safety: Designed for long-term use in patients across different stages of prostate cancer.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 10.04.2026
Similar products
What Customers Say
No reviews yet
Your review can be the first!